Results 151 to 160 of about 1,369 (198)

A case of acute embolic stroke resulting from endocarditis and aortic aneurysm concurrent with aortic dissection in a healthy young patient: a case report. [PDF]

J Med Case Rep
Ansari SH, Salehi M, Parsa NA, Mousavi AF.   +3 more
europepmc   +1 more source

Drug-induced Pleuritis Associated with Hachimijiogan. [PDF]

Intern Med
Kuroda K, Nakazaki H, Shibata Y, Yamasaki A.   +3 more
europepmc   +1 more source

Anesthetic and Transfusion Management of an Immunosuppressed Patient With Infective Endocarditis and Severe Platelet Allergy Undergoing Redo Aortic Root Surgery. [PDF]

Cureus
Sarridou D, Ioannidis R, Iatridi F, Mitos G, Amaniti E.   +4 more
europepmc   +1 more source

Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets.

Indian J Pharm Sci, 2008
Vora DN, Kadav AA.
europepmc   +1 more source

A REVIEW ON ANALYTICAL METHOD FOR THE ESTIMATION OF TELMISARTAN AND BISOPROLOL FUMARATE

International Journal of Biology, Pharmacy and Allied Sciences
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Method of Validation for Residual Solvents in Bisoprolol Fumarate by GC Technique

Asian Journal of Pharmaceutical Research, 2021
Validation is important technique for detection, progress and estimation of drugs for pharmaceutical analysis. Aim of this article was to check the progress and validation of the method employed for the Residual Solvents in Bisoprolol Fumarate by Gas Chromatographic technique.
Sandip A Telavane, Seema Kothari, Manohar V. Lokhande   +2 more
openaire   +1 more source

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate

Journal of Pharmaceutical Sciences, 2014
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing bisoprolol as the sole active pharmaceutical ingredient (API) are reviewed.
Charoo, NA, Shamsher, AAA, Lian, LY, Abrahamsson, B, Cristofoletti, R, Groot, DW, Kopp, S, Langguth, P, Polli, J, Shah, VP, Dressman, J   +10 more
openaire   +3 more sources

Incompatibility of Bisoprolol Fumarate with Some Super-disintegrating Agents

British Journal of Pharmaceutical Research, 2015
Aims: Bisoprolol fumarate, a selective β1adrenoreceptor blocker, is usually formulated as immediate release tablet dosage form. While developing the immediate release tablet formula in laboratory, the assay and dissolution results were found below acceptance limit in some formulation. The formulations differed only in disintegrating agents. Therefore a
Abu Shakar, Md Hossain, Ruhul Kayesh, Asma Rahman, Md Sultan   +4 more
openaire   +1 more source

SIMULTANEOUS ESTIMATION OF IVABRADINE HCl AND BISOPROLOL FUMARATE BY UV-SPECTROSCOPIC METHOD

GLOBAL JOURNAL FOR RESEARCH ANALYSIS, 2022
A simple UV spectrophotometric analytical method has been developed for simultaneous estimation of Ivabradine HCl and Bisoprolol used in the treatment of angina pectoris. Modied simultaneous equation method was developed with double beam UV-Visible spectrophotometer using water as a solvent.
Pushpak Pandit, Vraj Sheth, Savan Viradiya, Mansi Patel, Dimal A. Shah, Usmangani K. Chhalotiya   +5 more
openaire   +1 more source